Quan R - Search Results

1

A retrospective analysis of efficacy and safety of adding bevacizumab to chemotherapy as first- and second-line therapy in advanced non-small-cell lung cancer (NSCLC).

Quan R, Huang J, Chen N, Fang W, Hu Z, Zhan J, Zhou T, Zhang L, Zhang H. Quan R, et al. Tumour Biol. 2016 Aug;37(8):11479-84. doi: 10.1007/s13277-016-5031-0. Epub 2016 Mar 25. Tumour Biol. 2016. PMID: 27012553

2

Comparison of efficacy in adjuvant chemotherapy regimens in patients with radically resected gastric cancer : a propensity-matched analysis.

Quan R, Huang J, Chen H, Liao Y, Lv W, Chen N, Liu J, Zhang H, Xu D. Quan R, et al. Oncotarget. 2016 Nov 15;7(46):76316-76326. doi: 10.18632/oncotarget.11783. Oncotarget. 2016. PMID: 27602756 Free PMC article.

3

Survival analysis of patients with glioblastoma treated by long-term administration of temozolomide.

Quan R, Zhang H, Li Z, Li X. Quan R, et al. Medicine (Baltimore). 2020 Jan;99(2):e18591. doi: 10.1097/MD.0000000000018591. Medicine (Baltimore). 2020. PMID: 31914038 Free PMC article.

4

Do patients receive any benefit from the addition of perioperative immunotherapy-chemotherapy for solid tumors?

Quan R, Li Z, Zhang H, Li X. Quan R, et al. Medicine (Baltimore). 2023 Oct 20;102(42):e35603. doi: 10.1097/MD.0000000000035603. Medicine (Baltimore). 2023. PMID: 37861545 Free PMC article.

5

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma.

Wu S, Quan R, Han L, Zhang H, Zhang B, Xu G, Li X. Wu S, et al. Among authors: quan r. Medicine (Baltimore). 2020 Jul 24;99(30):e21325. doi: 10.1097/MD.0000000000021325. Medicine (Baltimore). 2020. PMID: 32791728 Free PMC article.

6

Role of exosomal miRNAs in brain metastasis affected by radiotherapy.

Li Z, Yang H, Ye L, Quan R, Chen M. Li Z, et al. Among authors: quan r. Transl Neurosci. 2021 Mar 31;12(1):127-137. doi: 10.1515/tnsci-2020-0163. eCollection 2021 Jan 1. Transl Neurosci. 2021. PMID: 33821195 Free PMC article.

7

A rare case of nasopharyngeal adenoid cystic carcinoma treated with cetuximab-based induction therapy followed by concurrent chemoradiotherapy.

Wu S, Liu J, Quan R, Han L. Wu S, et al. Among authors: quan r. Oral Oncol. 2019 Feb;89:161-163. doi: 10.1016/j.oraloncology.2018.12.022. Epub 2018 Dec 26. Oral Oncol. 2019. PMID: 30594461 No abstract available.

8

Trastuzumab-based therapy is effective for salivary duct carcinoma: Case report and review of the literature.

Wu S, Quan R, Han L. Wu S, et al. Among authors: quan r. Oral Oncol. 2019 Apr;91:121-122. doi: 10.1016/j.oraloncology.2019.02.015. Epub 2019 Mar 1. Oral Oncol. 2019. PMID: 30827840 Review. No abstract available.

9

Identification of miRNA signatures in serum exosomes as a potential biomarker after radiotherapy treatment in glioma patients.

Li Z, Ye L, Wang L, Quan R, Zhou Y, Li X. Li Z, et al. Among authors: quan r. Ann Diagn Pathol. 2020 Feb;44:151436. doi: 10.1016/j.anndiagpath.2019.151436. Epub 2019 Dec 11. Ann Diagn Pathol. 2020. PMID: 31865249

10

Effect of HIF-1αsiRNA-linked AuNRs on radiotherapy of nasopharyngeal carcinoma.

Xu G, Zhang H, Li Z, Wu S, Quan R, Mao K, Sheng Y, Li X. Xu G, et al. Among authors: quan r. Cell Mol Biol (Noisy-le-grand). 2020 Jul 31;66(5):185-190. Cell Mol Biol (Noisy-le-grand). 2020. PMID: 33040834

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

408 results

Search Page

Filters